Invention Grant
- Patent Title: Antibodies to MUC16 and methods of use thereof
-
Application No.: US15695311Application Date: 2017-09-05
-
Publication No.: US10759869B2Publication Date: 2020-09-01
- Inventor: David Spriggs , Dharmarao Thapi
- Applicant: Memorial Sloan Kettering Cancer Center
- Applicant Address: US NY New York
- Assignee: Memorial Sloan Kettering Cancer Center
- Current Assignee: Memorial Sloan Kettering Cancer Center
- Current Assignee Address: US NY New York
- Agency: Jones Day
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/30 ; G01N33/574 ; A61K39/00

Abstract:
The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to a polypeptide, or antigenic portion thereof, wherein the polypeptide is selected from a) MUC16 ectodomain polypeptide, b) MUC16 cytoplasmic domain polypeptide, and c) MUC16 extracellular domain polypeptide that contains a cysteine loop polypeptide. The invention's antibodies and compositions containing them are useful in diagnostic and therapeutic applications for diseases in which MUC16 is overexpressed, such as cancer.
Public/Granted literature
- US20180230231A1 ANTIBODIES TO MUC16 AND METHODS OF USE THEREOF Public/Granted day:2018-08-16
Information query